Essentiality of SLC7A11-mediated nonessential amino acids in MASLD
Science Bulletin · 2024-12 · 69 (23) · 3700-3716
DOI: 10.1016/j.scib.2024.09.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Bulletin, 2024-12. Verfasst von Jie Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Zhejia…. Hauptthemen laut MEDLINE: Ferroptosis, Amino Acid Transport System y+, Serine. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) remains a rapidly growing global health burden. Here, we report that the nonessential amino acid (NEAA) transporter SLC7A11 plays a key role in MASLD. In patients with MASLD, we found high expression levels of SLC7A11 that were correlated directly with clinical grade. Using both loss-of-function and gain-of-function genetic models, we found that Slc7a11 deficiency accelerated MASLD progression via classic cystine/cysteine deficiency-induced ferroptosis, while serine deficiency and a resulting impairment in de novo cysteine production were attributed to ferroptosis-induced MASLD progression in mice overexpressing hepatic Slc7a11. Consistent with these findings, we found that both serine supplementation and blocking ferroptosis significantly alleviated MASLD, and the serum serine/glutamate ratio was significantly lower in these preclinical disease models, suggesting that it might serve as a prognostic biomarker for MASLD in patients. These findings indicate that defects in NEAA metabolism are involved in the progression of MASLD and that serine deficiency-triggered ferroptosis may provide a therapeutic target for its treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Zhejiang University School of Medicine, Hangzhou 310058, China.
- The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Zhejiang University School of Medicine, Hangzhou 310058, China; The Second A…
- The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology, Zhejiang University School of Medicine, Hangzhou 310058, China; School of Public Health, School of Basic Medical…
- The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Zhejiang University School of Medicine, Hangzhou 310058, China. Electronic a…
Förderung
- Zhejiang University
- National Natural Science Foundation of China
Zitieren
APA
Shen, J., Xie, E., Shen, S., Song, Z., Li, X., Wang, F., & Min, J. (2024). Essentiality of SLC7A11-mediated nonessential amino acids in MASLD. Science Bulletin, 69(23), 3700-3716. https://doi.org/10.1016/j.scib.2024.09.019
Vancouver
Shen J, Xie E, Shen S, Song Z, Li X, Wang F, et al. Essentiality of SLC7A11-mediated nonessential amino acids in MASLD. Science Bulletin. 2024;69(23):3700-3716. doi:10.1016/j.scib.2024.09.019
BibTeX
@article{Shen2024,
author = {Shen, Jie and Xie, Enjun and Shen, Shuying and Song, Zijun and Li, Xiaopeng and Wang, Fudi and Min, Junxia},
title = {Essentiality of SLC7A11-mediated nonessential amino acids in MASLD},
journal = {Science Bulletin},
year = {2024},
volume = {69},
number = {23},
pages = {3700--3716},
doi = {10.1016/j.scib.2024.09.019}
}
EUVIMED